ClinicalTrials.gg
RecruitingNCT04894708Fuji AIUpdated Jun 28, 2023

Study on the Use of Artificial Intelligence (Fujifilm) for Polyp Detection in Colonoscopy

An interventional study of colonoscopy in Screening Colonoscopy, Colonoscopic Control After Polypectomy and Suspected Colon Polyps, sponsored by Universitätsklinikum Hamburg-Eppendorf. Recruiting at 10 sites in Germany. Open to participants aged 35 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-28.

Sponsored by Universitätsklinikum Hamburg-Eppendorf · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 6 months ago, but the record still lists the study as recruiting.
  • Started Oct 2020; still recruiting 6 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,572
Allocation
Randomized
Ages
35 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Polyps with a site in Germany — 4 open to participants now, 4 under way, 1 of them phase 3. Polyps · Germany.

Planned enrollment
Largest of 13
1,572 · median 225
Started
2020
with 1 other
No phase
11 of 22
2 open now
Registered
17th of 22
by date
Lead sponsor
3 of 22
Universitätsklinikum Hamburg-Eppendorf

Among the 22 studies in Polyps with a site in Germany, this one has the largest planned enrollment of the 13 interventional ones that give a count, is one of 2 that started in 2020, is one of 11 with no phase, and was the 17th registered.

Polyps

312 studies on the registry are indexed under Polyps; 59 are open to participants now.

Browse Polyps studies →

Open to participants now

4 of the 22 studies in Polyps with a site in Germany are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 34 Polyps studies recruiting now, 25 (74%) set no upper age limit and 6 (18%) stop at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 35 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Polyps with a site in Germany, or all of them as a file.
02

Study summary

Colonoscopy is currently the best method of detection of intestinal tumors and polyps, particularly because polyps can also be biopsied and removed. There is a clear correlation between the adenoma detection rate and prevented carcinomas, so adenoma detection rate is the main parameter for the outcome quality of diagnostic colonoscopy. The efficiency of preventive colonoscopy needs optimisation by increase in adenoma detection rate, as it is known from many studies that approximately 15-30% of all adenomas can be overlooked. This mainly applies to smaller and flat adenomas. However, since even smaller polyps may be relevant for colorectal cancer development, the aim of colonoscopy should be to preferably be able to recognize all polyps and other changes.The latest and by far the most interesting development in this field is the use of artificial intelligence systems. They consist of a switched-on software with a small computer connected to the endoscope processor; the patient's introduced endoscope is completely unchanged.

The present study therefore compares the adenoma detection rate (ADR) of the latest generation of devices with high-resolution imaging from Fujifilm with and without the connection of artificial intelligence.

Read the detailed description

Methods of Computer Vision (CV) and Artificial Intelligence (AI) provide completely new opportunities, e.g. in the automatic polyp detection and differentiation of a lesion based on its endoscopic image. Computer vision using artificial intelligence methods means the application of "trained" so-called deep neural net (DNN) with a set of defined images (e.g. everyday scenes) and well-known solutions ( e.g. name of the pictured item; c.f. e.g. the "ImageNet Challenge"). The technical feasibility of using AI algorithms in endoscopy has already been proven in many cases. In the present study, it is an AI system from Fujifilm, which is already clinically usable. By using Fujifilm high-resolution imaging devices in colonoscopies, AI will be added randomly.

03

Conditions studied

  • Screening Colonoscopy
  • Colonoscopic Control After Polypectomy
  • Suspected Colon Polyps

Browse trials for

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Persons> 35 years of age who are capable of giving
  • Planned diagnostic colonoscopy (clarification of symptoms, polyp follow-up)
  • Screening colonoscopy for men >50 or women > 55 years of age

Exclusion criteria

Exclusion Criteria:

  • Colon bleeding
  • Colon carcinoma
  • Known polyps for removal
  • Inflammatory bowel disease
  • Colonic stenosis
  • Other suspected colon disease for further clarification
  • Follow-up care after colon cancer surgery (partial colon resection)
  • Anticoagulant drugs that make a or polypectomy impossible
  • Poor general condition ()
  • Incomplete colonoscopy planned
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,572 participants (estimated)

Study arms

  • Other
    AI colonoscopy

    colonoscopy with artificial intelligence added

    Procedure: colonoscopy

  • Sham comparator
    conventional colonoscopy

    conventional colonoscopy

    Procedure: colonoscopy

Interventions

  • Procedurecolonoscopy

    addition of polyp detection algorithm by Fujifilm

06

What researchers measure

Primary outcomes

  1. Adenoma detection rate

    Difference in adenoma detection rate (all adenomas/all patients) between the two groups

    Time frame: during procedure to histological examination result, approximately 2 days

Secondary outcomes

  1. Patient rate difference

    Differences in the patient rate with adenomas (adenoma detection rate, i.e. rate of patients with at least one adenoma)

    Time frame: during procedure to histological examination result, approximately 2 days

  2. Adenoma subgroup differences

    Differences subgroups of adenomas (flat, small, high-grade dysplasia)

    Time frame: histological examination result, approximately 2 days

  3. rate of hyperplastic polyp detection in both groups

    Differences in the detection of hyperplastic polyps

    Time frame: histological examination result, approximately 2 days

  4. rate of polyp detection in preventive and diagnostic colonoscopy

    Differences in preventive vs. diagnostic colonoscopy

    Time frame: during procedure to histological examination result, approximately 2 days

  5. Switching number (BLI, LCI) in both groups

    number of switches to visual support by colour filters

    Time frame: during procedure

  6. incidence of reasons for switching to BLI/LCI

    reasons for switching to visual support by colour filters

    Time frame: during procedure

  7. quality of polyp detection rate by image evaluation

    differential diagnosis of colon polyps in both groups with/without CADEYE)

    Time frame: until 2 months after recruitment stop

07

Study locations

8 of 10 sites recruiting
  • Gastroenterologiepraxis Dr. Moog
    Kassel, Hessen 34127, Germany
    Terminated

    Not enrolling at this site.

  • Universitätsklinikum Leipzig
    Leipzig, Sachsen 04103, Germany
    Recruiting
  • GastroZentrum Lippe
    Bad Salzuflen, 32105, Germany
    Terminated

    Not enrolling at this site.

  • Gastroenterologie am Bayerischen Platz
    Berlin, 10825, Germany
    Recruiting
    • Stefan Schubert, Dr. · Contactgastroenterologen@berlin.de · +49 30 814 59
    • Peter Amerding, Dr. · Contactgastroenterologen@berlin.de · +49 30 814 59
    • Stefan Schubert, Dr. · Sub investigator
    • Peter Amerding, Dr. · Sub investigator
    • Thomas Liceni, Dr. · Sub investigator
  • University Hospital Bonn
    Bonn, 53127, Germany
    Recruiting
    • Dominik J Kaczmarek, PD Dr. · ContactDominik.Kaczmarek@ukbonn.de · +49 228-287
    • Dominik J Kaczmarek, PD Dr. · Principal investigator
  • University Hospital Eppendorf
    Hamburg, 20246, Germany
    Recruiting
    • Thomas Rösch, Prof. Dr · Contactt.roesch@uke.de · +49 40 7410
    • Guido Schachschal, Dr. · Contactg.schachschal@uke.de · +49 40 7410
    • Thomas Rösch, Prof. Dr. · Principal investigator
    • Guido Schachschal, Dr. · Sub investigator
    • Katharina Zimmermann-Fraedrich, Dr. · Sub investigator
  • St. Vinzenz-Hospital / Akademisches Lehrkrankenhaus der Universität zu Köln
    Köln, 50733, Germany
    Recruiting
  • University Hospital Magdeburg
    Magdeburg, 39120, Germany
    Recruiting
  • Marienhospital Osnabrück
    Osnabrück, 49074, Germany
    Recruiting
  • Asklepios Paulinen Klinik Wiesbaden
    Wiesbaden, 65197, Germany
    Recruiting
    • Andrea May, Prof. Dr. · Contactan.may@asklepios.com · +49 611 847
    • Andrea May, Prof. Dr. · Principal investigator
08

References and documents

Publications

  • Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008 Sep 18;359(12):1218-24. doi: 10.1056/NEJMoa0803597. Erratum In: N Engl J Med. 2009 Nov 12;361(20):2004. PubMed 18799558 ↗
  • Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, Bond JH, Waye JD, Schapiro M, Panish JF, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med. 1996 Jan 11;334(2):82-7. doi: 10.1056/NEJM199601113340204. PubMed 8531963 ↗
  • European Colorectal Cancer Screening Guidelines Working Group; von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, Lansdorp-Vogelaar I, Malila N, Minozzi S, Moss S, Quirke P, Steele RJ, Vieth M, Aabakken L, Altenhofen L, Ancelle-Park R, Antoljak N, Anttila A, Armaroli P, Arrossi S, Austoker J, Banzi R, Bellisario C, Blom J, Brenner H, Bretthauer M, Camargo Cancela M, Costamagna G, Cuzick J, Dai M, Daniel J, Dekker E, Delicata N, Ducarroz S, Erfkamp H, Espinas JA, Faivre J, Faulds Wood L, Flugelman A, Frkovic-Grazio S, Geller B, Giordano L, Grazzini G, Green J, Hamashima C, Herrmann C, Hewitson P, Hoff G, Holten I, Jover R, Kaminski MF, Kuipers EJ, Kurtinaitis J, Lambert R, Launoy G, Lee W, Leicester R, Leja M, Lieberman D, Lignini T, Lucas E, Lynge E, Madai S, Marinho J, Maucec Zakotnik J, Minoli G, Monk C, Morais A, Muwonge R, Nadel M, Neamtiu L, Peris Tuser M, Pignone M, Pox C, Primic-Zakelj M, Psaila J, Rabeneck L, Ransohoff D, Rasmussen M, Regula J, Ren J, Rennert G, Rey J, Riddell RH, Risio M, Rodrigues V, Saito H, Sauvaget C, Scharpantgen A, Schmiegel W, Senore C, Siddiqi M, Sighoko D, Smith R, Smith S, Suchanek S, Suonio E, Tong W, Tornberg S, Van Cutsem E, Vignatelli L, Villain P, Voti L, Watanabe H, Watson J, Winawer S, Young G, Zaksas V, Zappa M, Valori R. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51-9. doi: 10.1055/s-0032-1325997. Epub 2012 Dec 4. PubMed 23212726 ↗
  • Millan MS, Gross P, Manilich E, Church JM. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum. 2008 Aug;51(8):1217-20. doi: 10.1007/s10350-008-9315-3. Epub 2008 May 24. PubMed 18500502 ↗
  • Bretagne JF, Ponchon T. Do we need to embrace adenoma detection rate as the main quality control parameter during colonoscopy? Endoscopy. 2008 Jun;40(6):523-8. doi: 10.1055/s-2007-995786. Epub 2008 May 8. No abstract available. PubMed 18464196 ↗
  • Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306. doi: 10.1056/NEJMoa1309086. PubMed 24693890 ↗
  • Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13;362(19):1795-803. doi: 10.1056/NEJMoa0907667. PubMed 20463339 ↗
  • Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006 Dec 14;355(24):2533-41. doi: 10.1056/NEJMoa055498. PubMed 17167136 ↗
  • Adler A, Wegscheider K, Lieberman D, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Mross M, Scheel M, Schroder A, Gerber K, Stange G, Roll S, Gauger U, Wiedenmann B, Altenhofen L, Rosch T. Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12,134 examinations (Berlin colonoscopy project 3, BECOP-3). Gut. 2013 Feb;62(2):236-41. doi: 10.1136/gutjnl-2011-300167. Epub 2012 Mar 22. PubMed 22442161 ↗
  • Adler A, Aminalai A, Aschenbeck J, Drossel R, Mayr M, Scheel M, Schroder A, Yenerim T, Wiedenmann B, Gauger U, Roll S, Rosch T. Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. Clin Gastroenterol Hepatol. 2012 Feb;10(2):155-9. doi: 10.1016/j.cgh.2011.10.026. Epub 2011 Nov 2. PubMed 22056301 ↗
  • Adler A, Aschenbeck J, Yenerim T, Mayr M, Aminalai A, Drossel R, Schroder A, Scheel M, Wiedenmann B, Rosch T. Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial. Gastroenterology. 2009 Feb;136(2):410-6.e1; quiz 715. doi: 10.1053/j.gastro.2008.10.022. Epub 2008 Oct 15. PubMed 19014944 ↗
  • Adler A, Pohl H, Papanikolaou IS, Abou-Rebyeh H, Schachschal G, Veltzke-Schlieker W, Khalifa AC, Setka E, Koch M, Wiedenmann B, Rosch T. A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? Gut. 2008 Jan;57(1):59-64. doi: 10.1136/gut.2007.123539. Epub 2007 Aug 6. PubMed 17681999 ↗
  • Adler A, Roll S, Marowski B, Drossel R, Rehs HU, Willich SN, Riese J, Wiedenmann B, Rosch T; Berlin Private-Practice Gastroenterology Working Group. Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis Colon Rectum. 2007 Oct;50(10):1628-38. doi: 10.1007/s10350-007-9029-y. PubMed 17694415 ↗
  • Schachschal G, Mayr M, Treszl A, Balzer K, Wegscheider K, Aschenbeck J, Aminalai A, Drossel R, Schroder A, Scheel M, Bothe CH, Bruhn JP, Burmeister W, Stange G, Bahr C, Kiesslich R, Rosch T. Endoscopic versus histological characterisation of polyps during screening colonoscopy. Gut. 2014 Mar;63(3):458-65. doi: 10.1136/gutjnl-2013-304562. Epub 2013 Jun 28. PubMed 23812324 ↗
  • Schachschal G, Sehner S, Choschzick M, Aust D, Brandl L, Vieth M, Wegscheider K, Baretton GB, Kirchner T, Sauter G, Rosch T. Impact of reassessment of colonic hyperplastic polyps by expert GI pathologists. Int J Colorectal Dis. 2016 Mar;31(3):675-83. doi: 10.1007/s00384-016-2523-8. Epub 2016 Feb 4. PubMed 26847619 ↗
  • Zimmermann-Fraedrich K, Groth S, Sehner S, Schubert S, Aschenbeck J, Mayr M, Aminalai A, Schroder A, Bruhn JP, Blaker M, Rosch T, Schachschal G. Effects of two instrument-generation changes on adenoma detection rate during screening colonoscopy: results from a prospective randomized comparative study. Endoscopy. 2018 Sep;50(9):878-885. doi: 10.1055/a-0607-2636. Epub 2018 Jul 23. PubMed 30036893 ↗
  • Rosch T, Altenhofen L, Kretschmann J, Hagen B, Brenner H, Pox C, Schmiegel W, Theilmeier A, Aschenbeck J, Tannapfel A, von Stillfried D, Zimmermann-Fraedrich K, Wegscheider K. Risk of Malignancy in Adenomas Detected During Screening Colonoscopy. Clin Gastroenterol Hepatol. 2018 Nov;16(11):1754-1761. doi: 10.1016/j.cgh.2018.05.043. Epub 2018 Jun 11. PubMed 29902640 ↗
  • Pioche M, Denis A, Allescher HD, Andrisani G, Costamagna G, Dekker E, Fockens P, Gerges C, Groth S, Kandler J, Lienhart I, Neuhaus H, Petruzziello L, Schachschal G, Tytgat K, Wallner J, Weingart V, Touzet S, Ponchon T, Rosch T. Impact of 2 generational improvements in colonoscopes on adenoma miss rates: results of a prospective randomized multicenter tandem study. Gastrointest Endosc. 2018 Jul;88(1):107-116. doi: 10.1016/j.gie.2018.01.025. Epub 2018 Feb 4. PubMed 29410020 ↗
  • Bronzwaer MES, Dekker E, Weingart V, Groth S, Pioche M, Rivory J, Beyna T, Neuhaus H, Ponchon T, Allescher H, Fockens P, Rosch T. Feasibility, safety, and diagnostic yield of the Extra Wide Angle View (EWAVE) colonoscope for the detection of colorectal lesions. Endoscopy. 2018 Jan;50(1):63-68. doi: 10.1055/s-0043-120666. Epub 2017 Nov 13. PubMed 29132174 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2020 (actual). Primary completion is estimated for May 2024, 43 months after the start.

Of 68 non-industry interventional studies with no phase under Polyps, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 43 months is above that.

Counting every sponsor, half of 79 studies reached it within 23 months; a quarter within 12 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 1, 2020
First posted
May 20, 2021
StartActual
Oct 28, 2020
Primary completionEst.
May 2024
CompletionEst.
Sep 2024
Last update
Jun 28, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04894708
Collaborators
FUJIFILM Deutschland, Branch office of FUJIFILM Europe GmbH
Responsible party
Prof. Dr. Thomas Rösch (Director of Department of Interdisciplinary Endoscopy of University Hospital Hamburg Eppendorf, Universitätsklinikum Hamburg-Eppendorf) — Principal investigator
First posted
May 20, 2021
Start date
Oct 28, 2020
Primary completion
May 2024 (estimated)
Completion
Sep 2024 (estimated)
Last update
Jun 28, 2023

Study contacts

Thomas Rösch, Prof. Dr.
Contact
t.roesch@uke.de
+49 40 7410 ext. 50098
Guido Schachschal, PD Dr.
Contact
g.schachschal@uke.de
+49 40 7410 ext. 50814
Thomas Rösch, Prof. dr.
principal investigator · Universitätsklinikum Hamburg-Eppendorf

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion